 8. Patients must have adequate liver function as evidenced by the following: total bilirubin, and AST aspartate aminotransferase 2 times of institutional upper limit of normal assessed within 2 weeks of enrollment. If patient has extensive liver metastasis which is the main cause of abnormal liver function, this requirement does not apply. The Principal Investigator can use his or her clinical judgment. 